Skip to main content
Top
Published in: Ophthalmology and Therapy 1/2018

Open Access 01-06-2018 | Review

A Discussion of Commercially Available Intra-ocular Telescopic Implants for Patients with Age-Related Macular Degeneration

Authors: Hannah M. P. Dunbar, Felipe E. Dhawahir-Scala

Published in: Ophthalmology and Therapy | Issue 1/2018

Login to get access

Abstract

Age-related macular degeneration (AMD) is the leading cause of visual impairment in the western world, causing significant reduction in quality of life. Despite treatment advances, the burden of visual impairment caused by AMD continues to rise. In addition to traditional low vision rehabilitation and support, optical and electronic aids, and strategies to enhance the use of peripheral vision, implantable telescopic devices have been indicated as a surgical means of enhancing vision. Here we examine the literature on commercially available telescopic devices discussing their design, mode of action, surgical procedure and published outcomes on visual acuity, quality of life, surgical complication rates and cost effectiveness data where available.
Funding Article processing charges were funded by VisionCare Inc.
Literature
1.
go back to reference Wiliams RA, et al. The psychosocial impact of macular degeneration. Arch Ophthalmol. 1998;116:514–20.CrossRef Wiliams RA, et al. The psychosocial impact of macular degeneration. Arch Ophthalmol. 1998;116:514–20.CrossRef
2.
go back to reference Wong WL, et al. Global prevalence of age-related macular degeneration and disease burden projection for 2020 and 2040: a systematic review and meta-analysis. Lancet Glob Health. 2014;2:e106–16.CrossRefPubMed Wong WL, et al. Global prevalence of age-related macular degeneration and disease burden projection for 2020 and 2040: a systematic review and meta-analysis. Lancet Glob Health. 2014;2:e106–16.CrossRefPubMed
3.
go back to reference Brown DM, et al. Ranibizumab versus verteporfin photodynamic therapy for neovascular age-related macular degeneration: 2-year results of the ANCHOR study. Ophthalmology. 2009;116(57–65):e55. Brown DM, et al. Ranibizumab versus verteporfin photodynamic therapy for neovascular age-related macular degeneration: 2-year results of the ANCHOR study. Ophthalmology. 2009;116(57–65):e55.
4.
go back to reference Rosenfeld PJ, et al. Ranibizumab for neovascular age-related macular degeneration. N Engl J Med. 2006;355:1419–31.CrossRefPubMed Rosenfeld PJ, et al. Ranibizumab for neovascular age-related macular degeneration. N Engl J Med. 2006;355:1419–31.CrossRefPubMed
5.
go back to reference Heier JS, et al. Intravitreal aflibercept (VEGF trap-eye) in wet age-related macular degeneration. Ophthalmology. 2012;119:2537–48.CrossRefPubMed Heier JS, et al. Intravitreal aflibercept (VEGF trap-eye) in wet age-related macular degeneration. Ophthalmology. 2012;119:2537–48.CrossRefPubMed
6.
go back to reference Broadhead GK, Hong T, Chang AA. Treating the untreatable patient: current options for the management of treatment-resistant neovascular age-related macular degeneration. Acta Ophthalmol. 2014;92:713–23.CrossRefPubMed Broadhead GK, Hong T, Chang AA. Treating the untreatable patient: current options for the management of treatment-resistant neovascular age-related macular degeneration. Acta Ophthalmol. 2014;92:713–23.CrossRefPubMed
7.
go back to reference Martin DF, et al. Ranibizumab and bevacizumab for treatment of neovascular age-related macular degeneration: 2-year results. Ophthalmology. 2012;119:1388–98.CrossRefPubMedPubMedCentral Martin DF, et al. Ranibizumab and bevacizumab for treatment of neovascular age-related macular degeneration: 2-year results. Ophthalmology. 2012;119:1388–98.CrossRefPubMedPubMedCentral
9.
go back to reference Singer MA, et al. Improving quality of life in patients with end-stage age-related macular degeneration: focus on miniature ocular implants. Clin Ophthalmol. 2012;6:33–9.PubMed Singer MA, et al. Improving quality of life in patients with end-stage age-related macular degeneration: focus on miniature ocular implants. Clin Ophthalmol. 2012;6:33–9.PubMed
10.
go back to reference Ryan B. Fragmented vision. Survey of low vision services in the UK. London: Royal National Institute for the Blind; 1999. Ryan B. Fragmented vision. Survey of low vision services in the UK. London: Royal National Institute for the Blind; 1999.
11.
go back to reference Binns AM, et al. How effective is low vision service provision? A systematic review. Surv Ophthalmol. 2012;57:34–65.CrossRefPubMed Binns AM, et al. How effective is low vision service provision? A systematic review. Surv Ophthalmol. 2012;57:34–65.CrossRefPubMed
15.
go back to reference Reeves BC, Harper RA, Russell WB. Enhanced low vision rehabilitation for people with age related macular degeneration: a randomised controlled trial. Br J Ophthalmol. 2004;88:1443–9.CrossRefPubMedPubMedCentral Reeves BC, Harper RA, Russell WB. Enhanced low vision rehabilitation for people with age related macular degeneration: a randomised controlled trial. Br J Ophthalmol. 2004;88:1443–9.CrossRefPubMedPubMedCentral
16.
go back to reference Teh BL, et al. Optimizing cataract surgery in patients with age-related macular degeneration. Surv Ophthalmol. 2017;62:346–56.CrossRefPubMed Teh BL, et al. Optimizing cataract surgery in patients with age-related macular degeneration. Surv Ophthalmol. 2017;62:346–56.CrossRefPubMed
17.
go back to reference Orzalesi N, et al. The IOL-Vip System: a double intraocular lens implant for visual rehabilitation of patients with macular disease. Ophthalmology. 2007;114:860–5.CrossRefPubMed Orzalesi N, et al. The IOL-Vip System: a double intraocular lens implant for visual rehabilitation of patients with macular disease. Ophthalmology. 2007;114:860–5.CrossRefPubMed
18.
go back to reference Felipe A, et al. Optical analysis to predict outcomes after implantation of a double intraocular lens magnification device. J Cataract Refract Surg. 2007;33:1781–9.CrossRefPubMed Felipe A, et al. Optical analysis to predict outcomes after implantation of a double intraocular lens magnification device. J Cataract Refract Surg. 2007;33:1781–9.CrossRefPubMed
19.
go back to reference Amselem L, et al. Clinical magnification and residual refraction after implantation of a double intraocular lens system in patients with macular degeneration. J Cataract Refract Surg. 2008;34:1571–7.CrossRefPubMed Amselem L, et al. Clinical magnification and residual refraction after implantation of a double intraocular lens system in patients with macular degeneration. J Cataract Refract Surg. 2008;34:1571–7.CrossRefPubMed
20.
go back to reference Agarwal A, et al. Mirror telescopic intraocular lens for age-related macular degeneration: design and preliminary clinical results of the Lipshitz macular implant. J Cataract Refract Surg. 2008;34:87–94.CrossRefPubMed Agarwal A, et al. Mirror telescopic intraocular lens for age-related macular degeneration: design and preliminary clinical results of the Lipshitz macular implant. J Cataract Refract Surg. 2008;34:87–94.CrossRefPubMed
21.
go back to reference Jacob S. New Technology For AMD. The cataract surgeon’s solution to a retinal problem. Eurotimes 2012;17/18(123/1). Jacob S. New Technology For AMD. The cataract surgeon’s solution to a retinal problem. Eurotimes 2012;17/18(123/1).
22.
go back to reference Qureshi MA, et al. Injectable intraocular telescope: pilot study. J Cataract Refract Surg. 2015;41:2125–35.CrossRefPubMed Qureshi MA, et al. Injectable intraocular telescope: pilot study. J Cataract Refract Surg. 2015;41:2125–35.CrossRefPubMed
24.
go back to reference Rosser DA, et al. How sensitive to clinical change are ETDRS LogMAR visual acuity measurements? Investig Ophthalmol Vis Sci. 2003;44:3278–81.CrossRef Rosser DA, et al. How sensitive to clinical change are ETDRS LogMAR visual acuity measurements? Investig Ophthalmol Vis Sci. 2003;44:3278–81.CrossRef
25.
go back to reference Scharioth GB. New add-on intraocular lens for patients with age-related macular degeneration. J Cataract Refract Surg. 2015;41:1559–63.CrossRefPubMed Scharioth GB. New add-on intraocular lens for patients with age-related macular degeneration. J Cataract Refract Surg. 2015;41:1559–63.CrossRefPubMed
26.
go back to reference Nekolova J, et al. Scharioth Macula Lens: a new intraocular implant for low-vision patients with stabilized maculopathy-first experience. Olomouc: Biomedical papers of the Medical Faculty of the University Palacky; 2017. Nekolova J, et al. Scharioth Macula Lens: a new intraocular implant for low-vision patients with stabilized maculopathy-first experience. Olomouc: Biomedical papers of the Medical Faculty of the University Palacky; 2017.
27.
go back to reference Colenbrander A, Runge P. Can Jaeger numbers be standardized. Investig Ophthalmol Vis Sci. 2007;48:3563. Colenbrander A, Runge P. Can Jaeger numbers be standardized. Investig Ophthalmol Vis Sci. 2007;48:3563.
28.
go back to reference Lipshitz I, et al. An intraocular telescopic lens for macular degeneration. Ophthalmic Surg Lasers. 1997;28:513–7.PubMed Lipshitz I, et al. An intraocular telescopic lens for macular degeneration. Ophthalmic Surg Lasers. 1997;28:513–7.PubMed
29.
go back to reference Alio JL, et al. Intraocular telescopic lens evaluation in patients with age-related macular degeneration. J Cataract Refract Surg. 2004;30:1177–89.CrossRefPubMed Alio JL, et al. Intraocular telescopic lens evaluation in patients with age-related macular degeneration. J Cataract Refract Surg. 2004;30:1177–89.CrossRefPubMed
30.
go back to reference Hudson HL, et al. Implantable miniature telescope for the treatment of visual acuity loss resulting from end-stage age-related macular degeneration: 1-year results. Ophthalmology. 2006;113:1987–2001.CrossRefPubMed Hudson HL, et al. Implantable miniature telescope for the treatment of visual acuity loss resulting from end-stage age-related macular degeneration: 1-year results. Ophthalmology. 2006;113:1987–2001.CrossRefPubMed
31.
go back to reference Colby KA, et al. Surgical placement of an optical prosthetic device for end-stage macular degeneration: the implantable miniature telescope. Arch Ophthalmol. 2007;125:1118–21.CrossRefPubMed Colby KA, et al. Surgical placement of an optical prosthetic device for end-stage macular degeneration: the implantable miniature telescope. Arch Ophthalmol. 2007;125:1118–21.CrossRefPubMed
32.
go back to reference Hudson HL, et al. Implantable telescope for end-stage age-related macular degeneration: long-term visual acuity and safety outcomes. Am J Ophthalmol. 2008;146:664–73.CrossRefPubMed Hudson HL, et al. Implantable telescope for end-stage age-related macular degeneration: long-term visual acuity and safety outcomes. Am J Ophthalmol. 2008;146:664–73.CrossRefPubMed
33.
go back to reference Boyer D, et al. Long-term (60-month) results for the implantable miniature telescope: efficacy and safety outcomes stratified by age in patients with end-stage age-related macular degeneration. Clin Ophthalmol. 2015;9:1099–107.CrossRefPubMedPubMedCentral Boyer D, et al. Long-term (60-month) results for the implantable miniature telescope: efficacy and safety outcomes stratified by age in patients with end-stage age-related macular degeneration. Clin Ophthalmol. 2015;9:1099–107.CrossRefPubMedPubMedCentral
35.
36.
go back to reference Mangione CM, et al. Development of the 25-item National Eye Institute Visual Function Questionnaire. Arch Ophthalmol. 2001;119:1050–8.CrossRefPubMed Mangione CM, et al. Development of the 25-item National Eye Institute Visual Function Questionnaire. Arch Ophthalmol. 2001;119:1050–8.CrossRefPubMed
37.
go back to reference Bressler NM, et al. Potential public health impact of Age-Related Eye Disease Study results: AREDS report no. 11. Arch Ophthalmol. 2003;121:1621–4.CrossRefPubMed Bressler NM, et al. Potential public health impact of Age-Related Eye Disease Study results: AREDS report no. 11. Arch Ophthalmol. 2003;121:1621–4.CrossRefPubMed
38.
go back to reference Clemons TE, et al. National Eye Institute Visual Function Questionnaire in the Age-Related Eye Disease Study (AREDS): AREDS Report No. 10. Arch Ophthalmol. 2003;121:211–7.CrossRefPubMedPubMedCentral Clemons TE, et al. National Eye Institute Visual Function Questionnaire in the Age-Related Eye Disease Study (AREDS): AREDS Report No. 10. Arch Ophthalmol. 2003;121:211–7.CrossRefPubMedPubMedCentral
39.
go back to reference Lindblad AS, Clemons TE. Responsiveness of the National Eye Institute Visual Function Questionnaire to progression to advanced age-related macular degeneration, vision loss, and lens opacity: AREDS Report no. 14. Arch Ophthalmol. 2005;123:1207–14.CrossRefPubMed Lindblad AS, Clemons TE. Responsiveness of the National Eye Institute Visual Function Questionnaire to progression to advanced age-related macular degeneration, vision loss, and lens opacity: AREDS Report no. 14. Arch Ophthalmol. 2005;123:1207–14.CrossRefPubMed
40.
go back to reference Bass EB, et al. Patients’ perceptions of the value of current vision: assessment of preference values among patients with subfoveal choroidal neovascularization—The Submacular Surgery Trials Vision Preference Value Scale: SST Report No. 6. Arch Ophthalmol. 2004;122:1856–67.CrossRefPubMed Bass EB, et al. Patients’ perceptions of the value of current vision: assessment of preference values among patients with subfoveal choroidal neovascularization—The Submacular Surgery Trials Vision Preference Value Scale: SST Report No. 6. Arch Ophthalmol. 2004;122:1856–67.CrossRefPubMed
41.
go back to reference Miskala PH, et al. Surgery for subfoveal choroidal neovascularization in age-related macular degeneration: quality-of-life findings: SST report no. 12. Ophthalmology. 2004;111:1981–92.CrossRefPubMed Miskala PH, et al. Surgery for subfoveal choroidal neovascularization in age-related macular degeneration: quality-of-life findings: SST report no. 12. Ophthalmology. 2004;111:1981–92.CrossRefPubMed
42.
go back to reference Hawkins BS, et al. Surgery for subfoveal choroidal neovascularization in age-related macular degeneration: ophthalmic findings: SST report no. 11. Ophthalmology. 2004;111:1967–80.CrossRefPubMed Hawkins BS, et al. Surgery for subfoveal choroidal neovascularization in age-related macular degeneration: ophthalmic findings: SST report no. 11. Ophthalmology. 2004;111:1967–80.CrossRefPubMed
43.
go back to reference Globe DR, et al. The impact of visual impairment on self-reported visual functioning in Latinos: the Los Angeles Latino Eye Study. Ophthalmology. 2004;111:1141–9.CrossRefPubMed Globe DR, et al. The impact of visual impairment on self-reported visual functioning in Latinos: the Los Angeles Latino Eye Study. Ophthalmology. 2004;111:1141–9.CrossRefPubMed
44.
go back to reference Pappas A, Fortin M, Joondeph BC. SD-OCT imaging in eyes implanted with a miniature telescope. Retina Today. 2015;10(5). Pappas A, Fortin M, Joondeph BC. SD-OCT imaging in eyes implanted with a miniature telescope. Retina Today. 2015;10(5).
45.
go back to reference Joondeph BC. Anti-vascular endothelial growth factor injection technique for recurrent exudative macular degeneration in a telescope-implanted eye. Retin Cases Brief Rep. 2014;8:342–4.CrossRefPubMed Joondeph BC. Anti-vascular endothelial growth factor injection technique for recurrent exudative macular degeneration in a telescope-implanted eye. Retin Cases Brief Rep. 2014;8:342–4.CrossRefPubMed
46.
go back to reference Garfinkel RA, Berinstein DM, Frantz R. Treatment of choroidal neovascularization through the implantable miniature telescope. Am J Ophthalmol. 2006;141:766–7.CrossRefPubMed Garfinkel RA, Berinstein DM, Frantz R. Treatment of choroidal neovascularization through the implantable miniature telescope. Am J Ophthalmol. 2006;141:766–7.CrossRefPubMed
47.
go back to reference Brown GC, et al. Comparative effectiveness and cost-effectiveness of the implantable miniature telescope. Ophthalmology. 2011;118:1834–43.CrossRefPubMed Brown GC, et al. Comparative effectiveness and cost-effectiveness of the implantable miniature telescope. Ophthalmology. 2011;118:1834–43.CrossRefPubMed
50.
52.
go back to reference Elliott DB, et al. Demographic characteristics of the vision-disabled elderly. Investig Ophthalmol Vis Sci. 1997;38:2566–75. Elliott DB, et al. Demographic characteristics of the vision-disabled elderly. Investig Ophthalmol Vis Sci. 1997;38:2566–75.
53.
go back to reference Sunness JS, et al. Fixation patterns and reading rates in eyes with central scotomas from advanced atrophic age-related macular degeneration and Stargardt disease. Ophthalmology. 1996;103:1458–66.CrossRefPubMedPubMedCentral Sunness JS, et al. Fixation patterns and reading rates in eyes with central scotomas from advanced atrophic age-related macular degeneration and Stargardt disease. Ophthalmology. 1996;103:1458–66.CrossRefPubMedPubMedCentral
54.
go back to reference Whittaker SG, Lovie-Kitchin J. Visual requirements for reading. Optom Vis Sci Off Publ Am Acad Optom. 1993;70:54–65.CrossRef Whittaker SG, Lovie-Kitchin J. Visual requirements for reading. Optom Vis Sci Off Publ Am Acad Optom. 1993;70:54–65.CrossRef
55.
go back to reference Casten RJ, Rovner BW, Tasman W. Age-related macular degeneration and depression: a review of recent research. Curr Opin Ophthalmol. 2004;15:181–3.CrossRefPubMed Casten RJ, Rovner BW, Tasman W. Age-related macular degeneration and depression: a review of recent research. Curr Opin Ophthalmol. 2004;15:181–3.CrossRefPubMed
56.
go back to reference Nollett CL, et al. High prevalence of untreated depression in patients accessing low-vision services. Ophthalmology. 2016;123:440–1.CrossRefPubMed Nollett CL, et al. High prevalence of untreated depression in patients accessing low-vision services. Ophthalmology. 2016;123:440–1.CrossRefPubMed
57.
go back to reference Colenbrander A, et al. Rehabilitation and intraocular telescopes. Ophthalmology. 2008;115:1437–8 (author reply 1438).CrossRefPubMed Colenbrander A, et al. Rehabilitation and intraocular telescopes. Ophthalmology. 2008;115:1437–8 (author reply 1438).CrossRefPubMed
Metadata
Title
A Discussion of Commercially Available Intra-ocular Telescopic Implants for Patients with Age-Related Macular Degeneration
Authors
Hannah M. P. Dunbar
Felipe E. Dhawahir-Scala
Publication date
01-06-2018
Publisher
Springer Healthcare
Published in
Ophthalmology and Therapy / Issue 1/2018
Print ISSN: 2193-8245
Electronic ISSN: 2193-6528
DOI
https://doi.org/10.1007/s40123-018-0129-7

Other articles of this Issue 1/2018

Ophthalmology and Therapy 1/2018 Go to the issue
Obesity Clinical Trial Summary

At a glance: The STEP trials

A round-up of the STEP phase 3 clinical trials evaluating semaglutide for weight loss in people with overweight or obesity.

Developed by: Springer Medicine

Highlights from the ACC 2024 Congress

Year in Review: Pediatric cardiology

Watch Dr. Anne Marie Valente present the last year's highlights in pediatric and congenital heart disease in the official ACC.24 Year in Review session.

Year in Review: Pulmonary vascular disease

The last year's highlights in pulmonary vascular disease are presented by Dr. Jane Leopold in this official video from ACC.24.

Year in Review: Valvular heart disease

Watch Prof. William Zoghbi present the last year's highlights in valvular heart disease from the official ACC.24 Year in Review session.

Year in Review: Heart failure and cardiomyopathies

Watch this official video from ACC.24. Dr. Biykem Bozkurt discuss last year's major advances in heart failure and cardiomyopathies.